PubRank

Joseph F Grosso

Author PubWeight™ 67.28‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 2012 35.24
2 PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma. N Engl J Med 2014 10.10
3 Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol 2007 4.29
4 Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape. Cancer Res 2011 3.81
5 Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells. Blood 2007 2.93
6 Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells. Science 2009 2.76
7 A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells. Mol Immunol 2010 1.65
8 Tc17 CD8 T cells: functional plasticity and subset diversity. J Immunol 2009 1.54
9 Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model. Cancer Res 2009 1.51
10 A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression. J Pathol 2015 1.45
11 Radiotherapy augments the immune response to prostate cancer in a time-dependent manner. Prostate 2008 1.17
12 Tumor recognition and self-recognition induce distinct transcriptional profiles in antigen-specific CD4 T cells. J Immunol 2009 1.07
13 Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: role of vascular endothelial growth factor. J Immunol 2003 1.01
14 The expression of CCL2 by T lymphocytes of mammary tumor bearers: role of tumor-derived factors. Cell Immunol 2005 0.99
15 Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer. J Transl Med 2013 0.93
16 Combined treatment effects of radiation and immunotherapy: studies in an autochthonous prostate cancer model. Int J Radiat Oncol Biol Phys 2013 0.81
17 Anti-tumor effects of endogenous prostate cancer-specific CD8 T cells in a murine TCR transgenic model. Prostate 2011 0.81
18 A unique mucin immunoenhancing peptide with antitumor properties. Cancer Res 2004 0.80